Does TRAMETINIB DIMETHYL SULFOXIDE Cause Malignant neoplasm progression? 1,114 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,114 reports of Malignant neoplasm progression have been filed in association with TRAMETINIB DIMETHYL SULFOXIDE (Mekinist). This represents 6.8% of all adverse event reports for TRAMETINIB DIMETHYL SULFOXIDE.
1,114
Reports of Malignant neoplasm progression with TRAMETINIB DIMETHYL SULFOXIDE
6.8%
of all TRAMETINIB DIMETHYL SULFOXIDE reports
430
Deaths
319
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TRAMETINIB DIMETHYL SULFOXIDE?
Of the 1,114 reports, 430 (38.6%) resulted in death, 319 (28.6%) required hospitalization, and 38 (3.4%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRAMETINIB DIMETHYL SULFOXIDE. However, 1,114 reports have been filed with the FAERS database.
What Other Side Effects Does TRAMETINIB DIMETHYL SULFOXIDE Cause?
Death (2,998)
Pyrexia (2,660)
Rash (1,271)
Fatigue (1,143)
Nausea (1,085)
Chills (965)
Diarrhoea (867)
Vomiting (720)
Product use in unapproved indication (687)
Malaise (547)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TRAMETINIB DIMETHYL SULFOXIDE Alternatives Have Lower Malignant neoplasm progression Risk?
TRAMETINIB DIMETHYL SULFOXIDE vs TRANDOLAPRIL
TRAMETINIB DIMETHYL SULFOXIDE vs TRANDOLAPRIL\VERAPAMIL
TRAMETINIB DIMETHYL SULFOXIDE vs TRANEXAMIC ACID
TRAMETINIB DIMETHYL SULFOXIDE vs TRANYLCYPROMINE
TRAMETINIB DIMETHYL SULFOXIDE vs TRASTUZUMAB